Purchase Order 75N91019P00546

<p>The National Cancer Institute awarded a purchase order to Covaris, LLC for one E220 focused-ultrasonicator instrument valued at $132,195.00 on August 22, 2017. This is a Total Small Business set-aside, firm fixed-price acquisition. The ultrasonicator is procured for sample preparation and analysis at the National Cancer Institute facility in Rockville, Maryland. The order carries an ultimate completion date of October 17, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Covaris, LLC for $12,750.00 on November 9, 2018, with ultimate completion on November 9, 2019. Work is performed in Woburn, Massachusetts. The order is firm fixed price with no set-aside designation. Covaris is a small business concern specializing in genomic research equipment and sample preparation technologies utilizing proprietary Adaptive Focused Acoustics technology.</p>

<p>The National Cancer Institute awarded a purchase order to Covaris, LLC for $24,210.00 on June 16, 2020, with ultimate completion on June 17, 2021. The order covers laboratory supplies on a firm fixed-price basis with no set-aside designation. Performance takes place in Woburn, Massachusetts, where Covaris manufactures genomic research equipment and sample preparation technologies.</p>

<p>The National Institutes of Health awarded a purchase order to Covaris, LLC for $35,372.00 on July 15, 2019 for supply and installation of a Covaris S220 focused ultrasonicator. Place of performance is Woburn, Massachusetts. The order carries firm fixed pricing with an ultimate completion date of September 10, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Covaris, LLC for maintenance of a Covaris E220 ultrasonicator (serial number 003927) valued at $10,045.00, with an award date of April 21, 2020. The one-year maintenance contract runs from April 21, 2020 through April 20, 2021. Place of performance is Bethesda, Maryland. The contract carries firm fixed-price pricing and no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Covaris, LLC for $4,950.00 on February 1, 2018, with a final completion date of March 27, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Covaris is a small business concern based in Woburn, Massachusetts, specializing in genomic research equipment and sample preparation technologies.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Covaris, LLC for a Covaris LE220-PLUS Focused-Ultrasonicator (E220 upgrade) valued at $52,580 with an award date of August 28, 2018. Performance is located in Woburn, Massachusetts. The order carries a firm fixed price structure with an ultimate completion date of October 12, 2018. The underlying solicitation was posted July 23, 2018 with a due date of July 30, 2018.</p>

The National Cancer Institute awarded a purchase order to Covaris, LLC valued at $9,750.00 on March 16, 2018, for genomic research equipment and technologies. No set-aside applied. Place of performance is Bethesda, Maryland. The order carries a firm fixed price structure and an ultimate completion date of April 20, 2019. Covaris manufactures advanced genomic research instruments utilizing proprietary Adaptive Focused Acoustics technology, serving federal research agencies with specialized...

The National Human Genome Research Institute awarded a purchase order to Covaris, LLC for a one-year service plan covering LE220-PLUS equipment (serial number 3388 and WCS 5177) with a ceiling value of $17,255.00, awarded May 7, 2020, with performance through July 1, 2021. Place of performance is Woburn, Massachusetts. The order is firm-fixed-price with no set-aside designation. Covaris is a small business concern specializing in genomic research instrumentation and associated maintenance and...

The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed-price purchase order contract to Covaris, Inc., a for-profit limited liability company, for the acquisition of an E220 Focused UltraSonicator with water conditioning system and chiller. The total potential value of the contract is $120,935.00. The contract did not have a set-aside designation. According to the pre-solicitation notice, the Covaris E220...